Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy

被引:45
|
作者
Jassal, Davinder S.
Neilan, Tomas G.
Fifer, Michael A.
Palacios, Igor F.
Lowry, Patrica A.
Vlahakes, Gus J.
Picard, Michael H.
Yoerger, Danita M.
机构
[1] Massachusetts Gen Hosp, Cardiol Div, Cardiac Ultrasount Lab, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Med Sch, Dept Surg,Cardiac Surg Div, Boston, MA USA
关键词
echocardiography; hypertrophic obstructive cardiomyopathy; diastolic dysfunction; alcohol septal ablation;
D O I
10.1093/eurheartj/ehl106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Impaired diastolic function is responsible for many of the clinical features of hypertrophic cardiomyopathy. In patients with hypertrophic obstructive cardiomyopathy (HOCM) whose symptoms are refractory to medical therapy, alcohol septal. ablation (ASA) reduces left ventricular (W) outflow tract gradient, with short-term improvement in LV diastolic function. Little is known about the longer term impact of ASA on diastolic function. Methods and results We evaluated LV diastolic function at baseline and 1- and 2-year follow-up after successful ASA. In 30 patients (58 +/- 15 years, 22 men) who underwent successful ASA, New York Heart Association class was tower at 1-year follow-up compared with baseline (3.0 +/- 0.5 to 1.5 +/- 0.7; P < 0.0001). LV outflow tract gradient (76 +/- 37 to 19 +/- 12; P < 0.0001), interventricular septal. thickness (19 +/- 2 to 14 +/- 2; P < 0.0001), and left atrial. volume (26 +/- 5 to 20 +/- 4; P < 0.0001) were decreased. Significant improvement in E-wave deceleration time, isovolumic relaxation time, early diastolic mitral lateral annular velocity (E), mitral inflow propagation velocity (V-p), ratio of transmitral early LV fitting velocity (E) to early diastolic Doppler tissue imaging of the mitral annulus (E/E'), and E/V-p were observed at I year following successful ASA. These changes persisted in the subset cohort (n = 21) for whom 2-year data were available. Conclusion Successful ASA for HOCM leads to significant and sustained improvement in echocardiographic measures of diastolic function, which may contribute to improved functional status after successful ASA.
引用
收藏
页码:1805 / 1810
页数:6
相关论文
共 50 条
  • [21] Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
    Sorajja, Paul
    Ommen, Steve R.
    Holmes, David R., Jr.
    Dearani, Joseph A.
    Rihal, Charanjit S.
    Gersh, Bernard J.
    Lennon, Ryan J.
    Nishimura, Rick A.
    CIRCULATION, 2012, 126 (20) : 2374 - 2380
  • [22] Immediate Reduction in Left Ventricular End-Diastolic Pressure During Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy
    Tharp, Peyton
    Bidwell, Katrina
    Cook, Daniel
    Blaker, Noah
    Taylor, Eric
    Dorsey, Andrew
    Kramer, Courtney
    Fernandes, Valerian
    Nielsen, Chris
    CIRCULATION, 2021, 144
  • [23] Left Ventricular Systolic Function Following Alcohol Septal Ablation for Symptomatic Hypertrophic Cardiomyopathy
    Moss, Travis J.
    Krantz, Mori J.
    Zipse, Matthew M.
    Quaife, Robert A.
    Sauer, William H.
    Messenger, John C.
    Groves, Bertron M.
    Salcedo, Ernesto E.
    Schuller, Joseph L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (08): : 1401 - 1404
  • [24] Ventricular Arrhythmia Following Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
    Noseworthy, Peter A.
    Rosenberg, Michael A.
    Fifer, Michael A.
    Palacios, Igor F.
    Lowry, Patricia A.
    Ruskin, Jeremy N.
    Sanborn, Danita M.
    Picard, Michael H.
    Vlahakes, Gus J.
    Mela, Theofanie
    Das, Saumya
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (01): : 128 - 132
  • [25] The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
    Klopotowski, Mariusz
    Chojnowska, Lidia
    Malek, Lukasz A.
    Maczynska, Renata
    Kukula, Krzysztof
    Demkow, Marcin
    Witkowski, Adam
    Dabrowski, Maciej
    Karcz, Maciej
    Baranowski, Rafal
    Kusmierczyk-Droszcz, Beata
    Kruk, Mariusz
    Jamiolkowski, Jacek
    Kusmierczyk, Mariusz
    Szumowski, Lukasz
    Ruzyllo, Witold
    CLINICAL RESEARCH IN CARDIOLOGY, 2010, 99 (05) : 285 - 292
  • [26] The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
    Mariusz Klopotowski
    Lidia Chojnowska
    Lukasz A. Malek
    Renata Maczynska
    Krzysztof Kukula
    Marcin Demkow
    Adam Witkowski
    Maciej Dabrowski
    Maciej Karcz
    Rafal Baranowski
    Beata Kusmierczyk-Droszcz
    Mariusz Kruk
    Jacek Jamiolkowski
    Mariusz Kusmierczyk
    Lukasz Szumowski
    Witold Ruzyllo
    Clinical Research in Cardiology, 2010, 99 : 285 - 292
  • [27] Alcohol septal ablation in hypertrophic obstructive cardiomyopathy
    Ben-Dor, Itsik
    Maluenda, Gabriel
    Wang, Zuyue
    Lindsay, Joseph
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2012, 13 (01) : 72 - 74
  • [28] Alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    Knight, Charles J.
    HEART, 2006, 92 (09) : 1339 - 1344
  • [29] FOLFOX chemotherapy as a cause of ventricular septal rupture after alcohol septal ablation for obstructive hypertrophic cardiomyopathy?
    Liebregts, Max
    Bol, Guus M.
    Groen, Jan-Willem
    Lieuw-a-Fa, Mariska
    Heijmen, Robin H.
    ten Berg, Jurrien M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 207 : 208 - 210
  • [30] Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
    El Masry, Hicham
    Breall, Jeffrey A.
    CURRENT CARDIOLOGY REVIEWS, 2008, 4 (03) : 193 - 197